D.E. Shaw & Co’s Genesis Healthcare GEN Stock Holding History
Bought
Maintained
Sold
Other funds holding GEN
VCM
D.E. Shaw & Co's GEN Position: Q3 2019 in Review
D.E. Shaw & Co sold out of Genesis Healthcare (GEN) in Q3 2019, closing a stake of 10,700 shares — an estimated $13K sold.
D.E. Shaw & Co first reported a position in GEN in Q1 2015 and held it in 18 quarters. The position peaked at $1.05M in Q2 2018. 74 funds tracked by Wall St. Rank hold GEN as of Q3 2019.
- D.E. Shaw & Co reported no remaining Genesis Healthcare position as of Q3 2019 after selling out during the quarter.
- D.E. Shaw & Co sold 10,700 Genesis Healthcare shares in Q3 2019, an estimated $13K.
- D.E. Shaw & Co first reported a position in Genesis Healthcare in Q1 2015 and held it in 18 quarters.
- D.E. Shaw & Co's Genesis Healthcare position peaked at $1.05M in Q2 2018.
- 74 funds tracked by Wall St. Rank held Genesis Healthcare as of Q3 2019.
Based on D.E. Shaw & Co's 13F filing for Q3 2019, filed 14 Nov 2019.